Brief: Viracta Therapeutics announces reprioritization of resources to enhance focus on Nana-Val development program
06/11/2024 22:37
Nov 6 (Reuters) - Viracta Therapeutics Inc VIRX.O :
* VIRACTA THERAPEUTICS ANNOUNCES REPRIORITIZATION OF
RESOURCES TO
ENHANCE FOCUS ON NANA-VAL DEVELOPMENT PROGRAM IN PATIENTS WITH
RELAPSED OR REFRACTORY EBV-POSITIVE PERIPHERAL T-CELL LYMPHOMA
* VIRACTA THERAPEUTICS INC: IMPLEMENTS 42% WORKFORCE
REDUCTION
Source text: ID:nGNX4wNrZM
Further company coverage: VIRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Viracta Therapeutics
See all newsBrief: Viracta Therapeutics Announces Wind Down Of Operations
Brief: Viracta Therapeutics Announces Closure Of Naval-1 Clinical Trial And Exploration Of Strategic Alternatives
Brief: Viracta Therapeutics Receives Notice Of Non-Compliance From Nasdaq
Viracta Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Viracta Therapeutics Reports Q3 2024 Financial Results And Provides Business Update